Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

President Donald Trump’s approval rating dropped one point in Morning Consult’s weekly survey and improved two points in a CBS/YouGov poll out Sunday—as Americans’ feelings about his use of the ...

President Donald Trump’s approval rating improved two points from July, to 44%, in the latest CBS/YouGov survey that found feelings about his use of the National Guard to tamp down on crime in large U ...